These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 19422046

  • 1. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Mu P, Nagahara S, Makita N, Tarumi Y, Kadomatsu K, Takei Y.
    Int J Cancer; 2009 Dec 15; 125(12):2978-90. PubMed ID: 19422046
    [Abstract] [Full Text] [Related]

  • 2. Atelocollagen-mediated intravenous siRNA delivery specific to tumor tissues orthotopically xenografted in prostates of nude mice and its anticancer effects.
    Yuan Y, Makita N, Cao D, Mihara K, Kadomatsu K, Takei Y.
    Nucleic Acid Ther; 2015 Apr 15; 25(2):85-94. PubMed ID: 25692652
    [Abstract] [Full Text] [Related]

  • 3. siRNA-Based Drug Targeting Human Bcl-xL Against Cancers.
    Takei Y.
    Methods Mol Biol; 2019 Apr 15; 1974():31-40. PubMed ID: 31098993
    [Abstract] [Full Text] [Related]

  • 4. Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.
    Meryet-Figuière M, Lecerf C, Varin E, Coll JL, Louis MH, Dutoit S, Giffard F, Blanc-Fournier C, Hedir S, Vigneron N, Brotin E, Pelletier L, Josserand V, Denoyelle C, Poulain L.
    Oncol Rep; 2017 Oct 15; 38(4):1949-1958. PubMed ID: 28791387
    [Abstract] [Full Text] [Related]

  • 5. Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.
    Rieger C, Huebner D, Temme A, Wirth MP, Fuessel S.
    Int J Oncol; 2015 Sep 15; 47(3):1121-30. PubMed ID: 26201840
    [Abstract] [Full Text] [Related]

  • 6. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O, Tschopp S, Olie RA, Leech SH, Simões-Wüst AP, Ziegler A, Baumann B, Odermatt B, Hall J, Stahel RA, Zangemeister-Wittke U.
    J Natl Cancer Inst; 2001 Mar 21; 93(6):463-71. PubMed ID: 11259472
    [Abstract] [Full Text] [Related]

  • 7. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
    Yamanaka K, Rocchi P, Miyake H, Fazli L, So A, Zangemeister-Wittke U, Gleave ME.
    BJU Int; 2006 Jun 21; 97(6):1300-8. PubMed ID: 16686729
    [Abstract] [Full Text] [Related]

  • 8. Suppression of Bcl-xL expression by a novel tumor-specific RNA interference system inhibits proliferation and enhances radiosensitivity in prostatic carcinoma cells.
    Wang R, Lin F, Wang X, Gao P, Dong K, Wei SH, Cheng SY, Zhang HZ.
    Cancer Chemother Pharmacol; 2008 May 21; 61(6):943-52. PubMed ID: 17653717
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.
    Yu X, Yang L, Cairns MJ, Dass C, Saravolac E, Li X, Sun LQ.
    Oncotarget; 2014 Oct 15; 5(19):9039-48. PubMed ID: 25344863
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
    Hikita H, Takehara T, Shimizu S, Kodama T, Shigekawa M, Iwase K, Hosui A, Miyagi T, Tatsumi T, Ishida H, Li W, Kanto T, Hiramatsu N, Hayashi N.
    Hepatology; 2010 Oct 15; 52(4):1310-21. PubMed ID: 20799354
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Suppressing the growth of rectal cancer xenografts derived from patient tumors by an adenovector expressing small hairpin RNA targeting Bcl-XL.
    Zhu H, Zhou W, Hu J, Huang Z, Lao W, Huang X, He C.
    J Gene Med; 2012 Dec 15; 14(12):761-8. PubMed ID: 23169477
    [Abstract] [Full Text] [Related]

  • 17. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER, Arlotti JA, Marynowski SW, Singh SV.
    Clin Cancer Res; 2008 Feb 15; 14(4):1248-57. PubMed ID: 18281560
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.
    Forootan SS, Bao ZZ, Forootan FS, Kamalian L, Zhang Y, Bee A, Foster CS, Ke Y.
    Int J Oncol; 2010 Jan 15; 36(1):69-76. PubMed ID: 19956834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.